Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...

Biocon Biologics partners with Civica to enhance access to Insulin Aspart in the US, no tech transfer involved.

Biocon Biologics' own Insulin Aspart drug product for the US is currently under review by the US Food and Drug Administration ...

New research has uncovered a potential way to improve cardiometabolic health: fresh mangoes. A study recently published in ...

A study from Tübingen reveals that the brain plays a central role in the development of obesity. The prevalence of obesity ...

Biocon Biologics partners with Civica Inc to increase affordability and access to Insulin Aspart in the US, targeting the ...

This collaboration is in addition to Biocon Biologics’ own insulin aspart drug product for the US, which is currently under ...

Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical ...

The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...

Dr Pelz’s advice is not just about weight loss, it is about optimising health through a deeper understanding of the body’s natural rhythms. By being mindful of meal timing and avoiding eating after ...

A Cell Metabolism study finds that while high-GI meals spike insulin and glucose, they don’t increase hunger or consistently ...

Biocon Biologics on Thursday said it has tied up with not-for-profit generic drug and pharmaceutical firm Civica, Inc to expand access and affordability of Insulin Aspart in the US.